Core Biogenesis and Faravelli have developed a concept body formulation built around plant-produced biomimetic growth factors delivered in oleosome lipid capsules, extending actives previously reserved for facial skincare to the rest of the body. The product is not commercial; it functions as a demonstration that body care can be formulated around repair and renewal rather than surface hydration. The wider significance lies in skin being treated as a tissue with regenerative capacity rather than a cosmetic surface.
Key Points
- Plant-made biomimetic growth factors formulated for body, not face
- Oleosome lipid encapsulation used to deliver actives into skin
- Concept product demonstrates repair-focused formulation over surface moisturization
Longevity Analysis
Skin is the body's largest barrier organ, mediating defense, fluid retention, temperature regulation and immune surveillance, yet care below the neck has been dominated by occlusive moisturizers that address none of those functions. Formulating around growth factor signaling shifts the target from appearance to the tissue's own renewal capacity — the same principle that governs regeneration elsewhere in the body, where the useful intervention supports existing repair machinery rather than masking its decline. The practical question for anyone evaluating these products remains delivery and dose: encapsulation technology determines whether an active reaches viable tissue or remains a claim on a label.
Original published by Longevity.Technology, by Kyle Umipig.